POSC
Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers attrius PET scanner, clinical and technical services, and financing solutions enables healthcare providers to accurately diagnose cardiac disease, improve patient outcomes, and practice cost effective medicines. Positron Corporation was incorporated in 1983 and is based in Niagara Falls, New York.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.04 | $111,000 | -$788,710 |
| 2025 Q4 | -0.21 | $111,000 | -$1M |
| 2025 Q3 | -0.03 | $111,000 | -$1M |
| 2025 Q2 | -0.04 | $190,119 | — |
| 2025 Q1 | -0.05 | $119,333 | -$1M |
| 2024 Q4 | -0.04 | $136,000 | -$633,080 |
| 2024 Q3 | -0.01 | $136,000 | -$206,340 |
| 2024 Q2 | -0.02 | $157,750 | -$395,570 |